Orthofix Medical  logo
Orthofix Medical OFIX
$ 15.51 -1.27%

Quarterly report 2025-Q3
added 11-04-2025

report update icon

Orthofix Medical Cash Flow 2011-2025 | OFIX

Annual Cash Flow Orthofix Medical

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

25.8 M -45.8 M -11.5 M 18.5 M 74.3 M 32 M 49.9 M 39 M 59.1 M 43.6 M 51.2 M 67 M - -

Depreciation & Amortization

60.1 M 53.1 M 29 M 29.6 M 30.5 M 24.7 M 18.7 M 20.1 M 20.8 M 20.9 M 22.9 M 22.8 M 18.3 M 23.2 M

Accounts Payables

48.8 M 58.4 M 27.6 M 26.5 M 23.1 M - 18 M 18.1 M 14.4 M 16.4 M 13.2 M 20.7 M 21.8 M 20.1 M

Accounts Receivables

135 M 128 M 82.9 M 78.6 M 72.4 M 86.8 M 77.7 M 63.4 M 57.8 M 59.8 M 61.4 M 70.8 M 107 M 133 M

Total Inventories

189 M 222 M 100 M 83 M 84.6 M 82.4 M 76.8 M 81.3 M 63.3 M 57.6 M 59.8 M 72.7 M 83.4 M 83 M

All numbers in USD currency

Quarterly Cash Flow Orthofix Medical

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - -18.4 M - - - -18.6 M - - - -34 M - -13.9 M - -7.71 M - 6.7 M - 2.44 M - 52 M 30.1 M 12.5 M - 20.1 M 8.34 M -1.04 M - 28.8 M 13 M -3.56 M - 9.12 M -4.64 M -10.9 M - 38.4 M 21.4 M 4.65 M - 26.5 M 8.95 M 2.54 M - 36 M - - - - - - - - - - - - - -

Depreciation & Amortization

12.9 M 16.9 M 34.4 M - 15.2 M 14 M 14.9 M - 13.1 M 13.3 M 12.7 M - 7.57 M 6.51 M 7.52 M - 7.15 M 7.56 M 7.44 M - 9.03 M 6.94 M 6.33 M - 6.28 M 6.18 M 5.73 M - 4.74 M 4.55 M 4.37 M - 15.4 M 10.4 M 5.08 M - 15.5 M 10 M 4.87 M - - - 405 K - 508 K 661 K 5.75 M - 15.6 M 10.3 M 5.07 M - 15.6 M 11.1 M 5.72 M - 17.3 M 11.3 M 5.34 M

Accounts Payables

50.5 M 45.1 M 45.2 M 48.8 M 47.1 M 50.4 M 57.1 M 58.4 M 53.3 M 51.3 M 45.9 M 27.6 M 28 M - 27.4 M 26.5 M 19.4 M 20.1 M 21.1 M 23.1 M 23.1 M 23.1 M 23.1 M 19.9 M 19.9 M 19.9 M 19.9 M 18 M 18 M 18 M 18 M 18.1 M 13.4 M 18.1 M 18.1 M 14.4 M 14.4 M 14.4 M 14.4 M 16.4 M 16.4 M 16.4 M 16.4 M 13.2 M 13.2 M 13.2 M 13.2 M 20.7 M 20.7 M 20.7 M 20.7 M 22.6 M 22.6 M 22.6 M 21.8 M 18.2 M 16.5 M 16.5 M 20.1 M

Accounts Receivables

131 M 130 M 132 M 135 M 125 M 125 M 126 M 128 M 114 M 112 M 113 M 82.9 M 75.6 M - 72.5 M 78.6 M 69 M 73.5 M 69.7 M 72.4 M 72.4 M 72.4 M 72.4 M 86.8 M 86.8 M 86.8 M 86.8 M 77.7 M 77.7 M 77.7 M 77.7 M 63.4 M 63.4 M 63.4 M 63.4 M 57.8 M 57.8 M 57.8 M 57.8 M 59.8 M 59.8 M 59.8 M 59.8 M 61.4 M 61.4 M 61.4 M 61.4 M 70.8 M 70.8 M 70.8 M 70.8 M 104 M 107 M 107 M 107 M 99.9 M 133 M 133 M 147 M

Total Inventories

174 M 173 M 174 M 189 M 206 M 210 M 219 M 222 M 222 M 222 M 222 M 100 M 100 M - 88.8 M 83 M 84.7 M 81.6 M 84.2 M 84.6 M 84.6 M 84.6 M 84.6 M 82.4 M 82.4 M 82.4 M 82.4 M 76.8 M 76.8 M 76.8 M 76.8 M 81.3 M 81.3 M 81.3 M 81.3 M 63.3 M 63.3 M 63.3 M 63.3 M 57.6 M 57.6 M 57.6 M 57.6 M 59.8 M 59.8 M 59.8 M 59.8 M 72.7 M 72.7 M 72.7 M 72.7 M 69.8 M 83.4 M 83.4 M 83.4 M 81.5 M 83 M 83 M 91.2 M

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Orthofix Medical , reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Medical devices sector

Issuer Price % 24h Market Cap Country
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.86 -3.26 % $ 134 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Abiomed Abiomed
ABMD
- - $ 17.2 B usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 307.92 -1.93 % $ 8.69 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 45.13 -2.67 % $ 6.72 K usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 125.1 1.48 % $ 218 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 92.34 0.64 % $ 136 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 2.56 8.94 % $ 95.5 M franceFrance
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.92 -4.72 % $ 14.8 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 96.35 -1.06 % $ 1.22 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 17.7 -3.46 % $ 408 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
LivaNova PLC LivaNova PLC
LIVN
$ 62.79 -1.82 % $ 3.41 B britainBritain
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 2.53 0.86 % $ 99 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 14.56 0.76 % $ 1.15 B israelIsrael
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 9.88 0.05 % $ 709 M israelIsrael
Myomo Myomo
MYO
$ 1.06 -1.85 % $ 7.47 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 13.41 -4.56 % $ 1.03 B usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Align Technology Align Technology
ALGN
$ 165.15 0.78 % $ 12.4 B usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 1.07 -3.18 % $ 110 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 12.81 -1.23 % $ 346 M usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 14.86 -0.03 % $ 97.4 M usaUSA
AxoGen AxoGen
AXGN
$ 30.33 1.15 % $ 1.34 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 40.78 2.33 % $ 1.26 B usaUSA
LENSAR LENSAR
LNSR
$ 11.48 -0.17 % $ 132 M usaUSA